MedPath

PET/CT to Identify "Vulnerable" Arterial Plaque

Not Applicable
Conditions
Cancer
Registration Number
NCT00416065
Lead Sponsor
Rambam Health Care Campus
Brief Summary

The purpose of this research is to evaluate the presence, location and intensity of FDG uptake in the large arteries using the new technology of fused PET/CT imaging and to compare FDG uptake with the presence of arterial calcifications as seen on the simultaneously acquired CT, in order to determine if FDG was increases incalcified plaque or in a different location in the arterial wall. we will also evaluate the relationship between FDG localization and future cardiovascular events in out patient population

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
800
Inclusion Criteria
  • Patients referred for clinical FDG-PET/CT studies
  • Patients 50 yr or older
  • Patients signed informed consent
Exclusion Criteria
  • Patients unable or unwilling to tolerate the scan until its completion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
the impact of the imaging modality on patient management
Secondary Outcome Measures
NameTimeMethod
the impact of the imaging modality on patient management

Trial Locations

Locations (1)

Rambam Medical Center

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath